The Middle Path to Innovation | LSI Europe '24

Duke’s Keynote is based on his recently published thesis, "The Middle Path to Innovation," published in the Harvard Business Review. He discusses strategies for developing high-growth products in slow-growth companies and present the growth driver model.

The Global Stage for Live-Saving Innovation

We’re continuing to push the bar by bringing bold ideas and new capital into medtech. This year, we are thrilled to have Harry Stebbings, Founder of 20VC, join us to discuss lessons from the best founders, the AI landscape, and its impact on healthcare.

Visit here: https://rb.gy/fduqa8

Amber Therapeutics’ Series A: Behind the $100M Raise

During a panel at LSI Europe ’24, Amber’s CEO and Co-Founder Aidan Crawley joined a panel of investors to unpack how the round came together, what made Amber a standout, and why the hard work has only just begun.